High-dose influenza vaccine to reduce clinical outcomes in high risk cardiovascular patients: Rationale and design of the INVESTED trial
Conclusion INVESTED is the largest and longest study to assess whether high-dose influenza vaccine is superior to standard-dose influenza vaccine in reducing cardiopulmonary events in a high-risk cardiovascular population patients with heart failure and/or myocardial infarction (ClinicalTrials.gov Identifier: NCT02787044).
Source: American Heart Journal - Category: Cardiology Source Type: research
More News: Cardiology | Cardiovascular | Heart | Heart Attack | Heart Failure | Influenza | Influenza Vaccine | Legislation | Study | Vaccines